晚期大腸直腸癌新藥panitumumab (Vectibix®) | 合法藥品大搜索

Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, ... Read More

Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor medication used for the ... KRAS, since it had little or no effect in colorectal tumors harboring a KRAS mutation (this also applied to the EGFR antibody panitumumab). Read More

Vectibix® (panitumumab) is for treating patients with wild-type RAS metastatic colorectal cancer (cancer that has spread outside of the colon and rectum). RAS​ ... Read More

Class/mechanism: EGFR antagonist; recombinant human IgG2 kappa monoclonal antibody that binds to EGFR (human epidermal growth factor receptor), ... Read More

Panitumumab (Handelsname Vectibix; Hersteller Amgen) ist ein humaner monoklonaler Antikörper aus der Gruppe der Immunglobuline IgG2κ. Er bindet an den ... Read More

panitumumab的中文名为帕尼单抗，是一种结直肠癌治疗药。 ... 2014年5月23日，​FDA已批准Vectibix（帕尼单抗，panitumumab）联合FOLFOX（一种基于奥沙利 ... Read More

Vectibix®學名為panitumumab，為基因重組的全人類IgG2單株抗體，可與EGFR​形成高親和力及專一性的結合，抑制所有已知由EGFR誘發的受體自動磷酸化作用。 Read More

卡瑞利珠單抗[編輯] ... 卡瑞利珠單抗（Camrelizumab，研發代號SHR-1210，商品名艾瑞卡）（ INN ）是一種抗PD-1免疫檢查點抑制劑，正在針對肝細胞癌的適應症 ... Read More

Panitumumab est un anticorps monoclonal thérapeutique ciblant le récepteur EGFR. Articles connexes[modifier | modifier le code]. Liste d'anticorps monoclonaux ... Read More

來源：生物谷2014年5月23日，FDA已批准Vectibix（帕尼單抗，panitumumab）​聯合FOLFOX（一種基於奧沙利鉑的化療方案），用於野生型KRAS（外顯子2） ... Read More